Geldanamycin abrogates ErbB2 association with proteasome-resistant β-catenin in melanoma cells, increases β-catenin-E-cadherin association, and decreases β-catenin-sensitive transcription
Paolo Bonvini, Won G. An, Angelo Rosolen, Phongmai Nguyen, Jane Trepel, Antonio Garcia De Herreros, Mireia Dunach, Leonard M. Neckers
Dive into the research topics of 'Geldanamycin abrogates ErbB2 association with proteasome-resistant β-catenin in melanoma cells, increases β-catenin-E-cadherin association, and decreases β-catenin-sensitive transcription'. Together they form a unique fingerprint.